Literature DB >> 22016496

Cancer therapeutics: time to swim downstream?

Richard Steinman1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22016496      PMCID： PMC3228067          DOI： 10.1634/theoncologist.2011-0241

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  5 in total

Review 1.  Tumors as organs: complex tissues that interface with the entire organism.

Authors:  Mikala Egeblad; Elizabeth S Nakasone; Zena Werb
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

Review 2.  Stromal fibroblasts in cancer: a novel tumor-promoting cell type.

Authors:  Akira Orimo; Robert A Weinberg
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

3.  Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.

Authors:  Gemma Migneco; Diana Whitaker-Menezes; Barbara Chiavarina; Remedios Castello-Cros; Stephanos Pavlides; Richard G Pestell; Alessandro Fatatis; Neal Flomenberg; Aristotelis Tsirigos; Anthony Howell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-06-15       Impact factor: 4.534

Review 4.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 5.  Anti-cancer therapies targeting the tumor stroma.

Authors:  Valeska Hofmeister; David Schrama; Jürgen C Becker
Journal:  Cancer Immunol Immunother       Date:  2007-07-27       Impact factor: 6.968
  5 in total
  1 in total

Review 1.  The Basis of Oncoimmunology.

Authors:  A Karolina Palucka; Lisa M Coussens
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.